Invitrogen,Applied Biosystems, Johns Hopkins, U of Delaware, Los Alamos, EMBL, U of Miami, US Gov t, Axigenic, U of Sydney, Kyorin Pharmaceutical, ActivX, Separation Scientific, Plant Research International, JGI | GenomeWeb

Invitrogen to Acquire Bio Asia for $8M To Expand Company’s China Presence

Invitrogen announced Wednesday that it will acquire Bio Asia, a Chinese reagent supplier, for up to $8 million in cash, and plans to invest more than $20 million in China over the next five years, the company said.

Bio Asia, which is based in Shanghai and has branches in Beijing and Guangzhou, as well as 18 sales offices across China, provides sequencing reagents and custom R&D services. The company, which was founded in 1999, has approximately $5 million in revenues.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Nature this week: genetic link between birth weight and adult-onset diseases, and more.

Even with all the current enthusiasm for gene therapies, Tech Review cautions that they are mostly in the early stages of development.

DNA phenotyping puts a potential face to a suspect in a nearly 25-year-old murder, the AP reports.

Researchers discuss the need for antibody standards at a meeting, NPR reports.